These three biotech stocks are undervalued: Wedbush analyst
Biotech stocks have underperformed the S&P 500 over the past year but one investment expert remains bullish on the space. Andreas Argyrides, vice president of equity research at Wedbush Securities, told BNN Bloomberg on Tuesday that while a high interest r...